BPG BIO
"BPG BIO" is a word and design mark owned by BPGbio Inc., filed at the USPTO on March 28, 2023. It has been allowed and covers classes 5, 9, 42 and 44.
- Status
- Allowed
- Since October 13, 2026
- Filed
- March 28, 2023
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 97861879
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 4 classes
Who owns BPG BIO
The owner and representative on file with the office.
Owner
BPGbio Inc.
Framingham, United States
Representative
Lori J. Shyavitz, Esq.
McCarter & English, LLP
What the mark covers
The products and services BPG BIO is filed for, grouped by Nice class.
Pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for wounds; Clinical medical reagents; Diagnostic kits comprised of medical reagents for medical and clinical use in disease testing, bodily fluid testing, biometric testing, cardiovascular testing, heart rate testing, organ function testing, hydration testing, and nutrition testing
Downloadable computer software for compiling and analyzing scientific and medical data; Recorded computer software for compiling and analyzing scientific and medical data; Downloadable computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Recorded computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Downloadable computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Recorded computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications
Pharmaceutical, scientific, medical, biopharmaceutical and biotechnology research and development; Drug discovery services; Pharmaceutical and biopharmaceutical drug development services; Providing medical and scientific research information in the field of medicine and pharmaceuticals; Medical research services in the field of cancer; Medical testing for scientific research purposes in the field of metabolic condition and disease, cancer, biomarkers, endocrinology diseases, central nervous system diseases and inflammatory disorders; Medical research featuring the identification and validation of disease related biomarkers; Data mining; Research and development in the field of biomarkers; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Providing scientific information in the field of pharmaceuticals; Pharmaceutical and medical research in the field of outcomes research; Medical research featuring the identification and validation of disease related biomarkers for use in improved patient outcomes; Providing on-line, non-downloadable software applications to compile and analyze scientific and medical data; Software as a service (SAAS) services featuring software for big data analytics, and for collecting and analyzing data in the field of healthcare; Providing on-line, non-downloadable computer software for use in accessing and importing scientific and medical data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Platform as a service (PAAS) featuring computer software platforms for data collection, data analytics, data storage and data mining, for use in the field of healthcare
Providing medical information in the field of medicine and pharmaceuticals; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic, prognostic and theranostic screening and testing; Theranostic assessment of a disease or condition for medical purposes; Theranostic analysis services for medical purposes; Medical diagnostic and theranostic monitoring and reporting services; Health care services, namely, providing a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of patient diagnostic, admissions, discharge, transfer (ADT), electronic health records (EHR), molecular, biomarker, genomic medicine, and clinical data including medication and laboratory values with systems for output of customized knowledge and information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Patient outcome analysis services, namely, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses, treatments and therapies associated with a defined set of symptoms and evaluating patient records, disease markers and environmental factors to provide patients with information about possible diagnoses, treatments and therapies; Predictive modeling of data in the fields of medicine and healthcare, for medical diagnostic, prognostic and treatment purposes; Providing health information; Medical information; Providing health information, medical information, disease management information, and information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, said information provided to others
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 5 granted
- Sou extension 5 filed
- Sou teas extension received
- Notice of approval of extension request e-mailed
- Sou extension 4 granted
- Sou extension 4 filed
- Sou teas extension received
- Notice of approval of extension request e-mailed
- Sou extension 3 granted
10 earlier steps on the official record.
About BPG BIO
Who owns the trademark "BPG BIO"?
The USPTO trademark "BPG BIO" (application 97861879) is owned by BPGbio Inc.
What is the status of "BPG BIO"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull BPG BIO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b87-d828-75e6-be54-c6de1b0ea9e3
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b87-d828-75e6-be54-c6de1b0ea9e3",
"object": "trademark",
"mark_text": "BPG BIO",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "97861879",
"filing_date": "2023-03-28",
"nice_classes": [
5,
9,
42,
44
],
"owners": [
{
"name": "BPGbio Inc.",
"entity_id": null
}
]
}